Researchers have developed synthetic peptides that target and inhibit the small, toxic protein aggregates that are thought to trigger Alzheimer’s disease. Neurons in the human brain make a protein called amyloid beta. Such proteins on their own, called monomers of amyloid beta, perform important tasks for neurons. But in the brains of people with Alzheimer’s disease, amyloid beta monomers have abandoned their jobs and joined together. First, they form oligomers – small clumps of up to a dozen proteins – then longer strands and finally large deposits called plaques...
Read More- Ultimate 3D Printer Guide/ Review/ MakerBot
- Amazing Science Facts
- Exotic Flowers
- Astronomy/Space
- Biology/Biotechnology
- Chemistry/Nanotechnology
- Environment/Geology
- Health/Medical
- Physics
- Interactive Physics
- Technology/Electronics
- Privacy Policy
- Best Port Solar Chargers/Power Banks on a Budget 2023
- Modern Healthcare and Technology
- The Advance of IoT, 5G and 6G
Recent Comments